MADRIGAL PHARMACEUTICALS INC revenue breakdown overview

MADRIGAL PHARMACEUTICALS INC revenue for the last year amounted to 174.00 M EUR, the most of which — 174.00 M EUR — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 111.50 k EUR. The greatest contribution to the revenue figure was made by United States — last year it brought MADRIGAL PHARMACEUTICALS INC 174.00 M EUR, and the year before that — 111.50 k EUR.